For the 5th time, Red Glead team receives the DI Gasell award – an annual recognition of the fastest growing companies in Sweden.
Red Glead Discovery was founded as a drug discovery company by 7 scientists in 2011, after the closure of the AstraZeneca site in Lund. Since the start Red Glead has continuously grown its revenues and the annual growth rate is currently at 33% (as an average over the last three financial years). During the last year, the organisation of approximately 55 employees has been significantly strengthened to support the continuous expansion. This includes the recruitment of a chief financial officer and a human resources manager.
“Becoming a 2022 DI Gasell fits our strategy to become a leading, innovative, and sustainable European drug discovery company. I am very proud of our dedicated co-workers and thankful for our many great collaborations with clients, suppliers and partners.”
Johan Evenäs, CEO at Red Glead
